MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors

NCT00003028 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

NETWORK

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: sabarubicin

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC